These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18534361)

  • 1. Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead.
    Kallinen LM; Hauser RG; Lee KW; Almquist AK; Katsiyiannis WT; Tang CY; Melby DP; Gornick CC
    Heart Rhythm; 2008 Jun; 5(6):775-9. PubMed ID: 18534361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead integrity alert algorithm decreases inappropriate shocks in patients who have Sprint Fidelis pace-sense conductor fractures.
    Kallinen LM; Hauser RG; Tang C; Melby DP; Almquist AK; Katsiyiannis WT; Gornick CC
    Heart Rhythm; 2010 Aug; 7(8):1048-55. PubMed ID: 20493965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Lead Integrity Alert to assist in the clinical diagnosis of implantable cardioverter defibrillator lead failures: analysis of different implantable cardioverter defibrillator leads.
    Ellenbogen KA; Gunderson BD; Stromberg KD; Swerdlow CD
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1169-77. PubMed ID: 24099976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead.
    Hauser RG; Kallinen LM; Almquist AK; Gornick CC; Katsiyiannis WT
    Heart Rhythm; 2007 Jul; 4(7):892-6. PubMed ID: 17599673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of inappropriate ICD shocks due to lead insulation failure by continuous monitoring and automatic alert.
    Gelder RN; Gunderson BD
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):e150-3. PubMed ID: 22309317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads.
    Swerdlow CD; Gunderson BD; Ousdigian KT; Abeyratne A; Stadler RW; Gillberg JM; Patel AS; Ellenbogen KA
    Circulation; 2008 Nov; 118(21):2122-9. PubMed ID: 18981299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of high-voltage conductor fractures in Sprint Fidelis leads.
    Koneru JN; Gunderson BD; Sachanandani H; Wohl BN; Kendall KT; Swerdlow CD; Ellenbogen KA
    Heart Rhythm; 2013 Jun; 10(6):813-8. PubMed ID: 23454808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure.
    Hauser RG; Hayes DL
    Heart Rhythm; 2009 May; 6(5):605-10. PubMed ID: 19285920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerating risk of Fidelis lead fracture.
    Farwell D; Green MS; Lemery R; Gollob MH; Birnie DH
    Heart Rhythm; 2008 Oct; 5(10):1375-9. PubMed ID: 18783996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate implantable cardioverter defibrillator shocks in fractured Sprint Fidelis leads associated with 'appropriate' interrogation.
    Farwell D; Redpath C; Birnie D; Gollob M; Lemery R; Posan E; Green M
    Europace; 2008 Jun; 10(6):726-8. PubMed ID: 18456645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lead electrical parameters may not predict integrity of the Sprint Fidelis ICD lead.
    Maytin M; Epstein LM
    Heart Rhythm; 2012 Sep; 9(9):1446-51. PubMed ID: 22537883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards eradication of inappropriate therapies for ICD lead failure by combining comprehensive remote monitoring and lead noise alerts.
    Ploux S; Swerdlow CD; Strik M; Welte N; Klotz N; Ritter P; Haïssaguerre M; Bordachar P
    J Cardiovasc Electrophysiol; 2018 Aug; 29(8):1125-1134. PubMed ID: 29858871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitation of programmed alerts to predict ICD lead failures.
    Vlay SC
    Pacing Clin Electrophysiol; 2009 Apr; 32(4):554-5. PubMed ID: 19335870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of lead failure manifestation of Biotronik Linox with St. Jude Medical Riata and Medtronic Sprint Fidelis lead.
    Lam A; Buehler S; Goulouti E; Sweda R; Haeberlin A; Medeiros-Domingo A; Servatius H; Seiler J; Baldinger S; Noti F; Tanner H; Roten L
    J Interv Card Electrophysiol; 2019 Mar; 54(2):161-170. PubMed ID: 30471050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of ventricular oversensing in implantable cardioverter-defibrillators: implications for diagnosis of lead fracture.
    Gunderson BD; Swerdlow CD; Wilcox JM; Hayman JE; Ousdigian KT; Ellenbogen KA
    Heart Rhythm; 2010 May; 7(5):626-33. PubMed ID: 20184977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple ICD discharges associated with lead fracture without triggering of high impedance alert.
    Donaldson DM; Singh JP; Heist EK; Mela T; Ruskin JN; Das S
    Pacing Clin Electrophysiol; 2009 Apr; 32(4):543-6. PubMed ID: 19335867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we predict and prevent adverse events related to high-voltage implantable cardioverter defibrillator lead failure?
    Ricci RP; Pignalberi C; Magris B; Aquilani S; Altamura V; Morichelli L; Porfili A; Quarta L; Saputo F; Santini M
    J Interv Card Electrophysiol; 2012 Jan; 33(1):113-21. PubMed ID: 21882010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead.
    Morrison TB; Rea RF; Hodge DO; Crusan D; Koestler C; Asirvatham SJ; Bradley D; Shen WK; Munger TM; Hammill SC; Friedman PA
    J Cardiovasc Electrophysiol; 2010 Jun; 21(6):671-7. PubMed ID: 20082653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee.
    Krahn AD; Champagne J; Healey JS; Cameron D; Simpson CS; Thibault B; Mangat I; Tung S; Sterns L; Birnie DH; Exner DV; Parkash R; Sivakumaran S; Davies T; Coutu B; Crystal E; Wolfe K; Verma A; Stephenson EA; Sanatani S; Gow R; Connors S; Paredes FA; Essebag V;
    Heart Rhythm; 2008 May; 5(5):639-42. PubMed ID: 18452862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.